Overview:
VDOT-M combines the proven efficacy of Vildagliptin and Metformin Hydrochloride to provide effective blood sugar management in Type 2 Diabetes Mellitus. This dual-therapy tablet helps the body utilize insulin more efficiently and reduces the amount of glucose produced by the liver — promoting better long-term glycemic control.

How It Works:

• Vildagliptin: A DPP-4 inhibitor that increases incretin hormone levels, enhances insulin secretion, and reduces glucagon release in a glucose-dependent manner.

• Metformin Hydrochloride: A biguanide that lowers blood sugar by reducing hepatic glucose output, limiting intestinal glucose absorption, and improving insulin sensitivity.

Key Benefits:
✅ Controls blood sugar levels effectively in Type 2 Diabetes
✅ Enhances insulin response and glucose metabolism
✅ Reduces glucose production in the liver
✅ Improves overall glycemic stability

Dosage & Usage:
The dosage is individualized according to patient needs and medical advice. Typically taken twice daily with meals to reduce gastrointestinal discomfort associated with Metformin.

Side Effects:
Minor effects may include nausea, vomiting, diarrhea, or loss of appetite. Rare adverse reactions such as lactic acidosis, pancreatitis, or hypersensitivity may occur. Regular monitoring of blood glucose and kidney function is recommended.

Product Specifications:

• Brand Name: VDOT-M

• Active Ingredients: Vildagliptin and Metformin Hydrochloride

• Category: Antidiabetic Tablets

• Shelf Life: 24 months

• Pack Type: Box

• Pack Size: 142 Tablets

• Manufacturer: Chemisis Pharmaceuticals

Note: To be used only under medical supervision. Always follow your healthcare provider’s prescription for dosage and duration.